Skip to main content
OpenTrials

Clinical trial condition

Systemic Lupus Erythematosus

Explore clinical trials studying Systemic Lupus Erythematosus. Study availability and eligibility vary by location and protocol.

499 public trials 116 recruiting studies
Refine in advanced search Browse all conditions

Systemic Lupus Erythematosus trial results

Recruiting

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

NCT06916806

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +17 more
Locations
  • Research Site Anniston, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site La Jolla, California, United States
  • Research Site Sacramento, California, United States
View all 37 locations
View Trial Details
Recruiting

A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)

NCT07363590

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +9 more
Locations
  • Gold Coast University Hospital ( Site 1601) Southport, Queensland, Australia
  • Anima Diepenbeek ( Site 0601) Diepenbeek, Limburg, Belgium
  • UZ Gent ( Site 0602) Ghent, Oost-Vlaanderen, Belgium
  • Chinese Academy of Medical Science Peking Union Medical College Hospital ( Site 1501) Beijing, Beijing Municipality, China
View all 21 locations
View Trial Details
Recruiting

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

NCT07570862

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +15 more
Locations
  • Wallace Rheumatic Studies Center Beverly Hills, California, United States
  • Providence Medical Foundation Fullerton, California, United States
  • Miami Dermatology and Laser Research Miami, Florida, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT06617325

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Sl0044 50058 Avondale, Arizona, United States
  • Sl0044 50550 Chandler, Arizona, United States
  • Sl0044 50713 Gilbert, Arizona, United States
  • Sl0044 50662 Glendale, Arizona, United States
View all 242 locations
View Trial Details
Recruiting

A Study of LY4298445 in Healthy Participants and Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

NCT07276958

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +10 more
Locations
  • Nucleus Network Brisbane, Australia
  • Nucleus Network Melbourne, Australia
  • Peking University First Hospital Beijing, China
  • Peking University Third Hospital Beijing, China
View Trial Details

Related conditions